AI Deployment & Workflow

AI Agents for Regulated Workflows

AI delivers value when agents are embedded in real work. USDM helps regulated teams deploy AI into intake triage, drafting, review, knowledge retrieval, evidence capture, and exception handling so work moves faster across Quality, Regulatory, Clinical, Manufacturing, Commercial/Medical, and IT/Ops.

Contact USDM Explore details

AI in life sciences · life sciences AI consulting · AI consulting for pharma and biotech

Life Sciences AI Strategy Starts with a Compliant Foundation

AI in life sciences delivers value when strategy, implementation, and compliance move together. From AI readiness assessments and governance models to audit-ready deployment frameworks, USDM brings the consulting depth regulated organizations need to operationalize AI with confidence. Across pharma, biotech, and broader GxP environments, USDM connects AI strategy to practical implementation, helping teams accelerate innovation without losing control of risk, quality, or regulatory alignment.

Read the Blog Download our AI Assurance Datasheet

AI governance life sciences · regulated AI · AI validation

AI Governance for Compliant, Scalable Life Sciences AI

AI adoption in life sciences now depends on governance that can withstand regulatory scrutiny, platform change, and operational scale. This white paper outlines an enterprise framework for compliant AI, covering lifecycle oversight, vendor risk, validated AI systems, and governance in GxP environments. USDM brings together AI strategy, regulatory depth, and digital trust expertise to support scalable, inspection-ready AI programs.

Learn More Download the White Paper

AI for quality, regulatory, PV, clinical, validation, CAPA, and deviation management

47 Applied AI Use Cases for Life Sciences Teams

AI in life sciences gets real when it solves operational bottlenecks across quality, regulatory, clinical, manufacturing, and pharmacovigilance. This white paper outlines 47 applied AI use cases designed for regulated environments, with measurable impact and inspection-aware architecture. USDM combines domain expertise, digital quality strategy, and practical deployment thinking to help organizations identify where AI can deliver value fastest and scale responsibly.

Learn More. Download the White Paper

trusted AI · responsible AI · AI risk management · explainable AI

AI Oversight Starts After Validation

Validating an AI system for a GxP-regulated environment is only the first step. As models evolve, data shifts, and regulations change, life sciences companies need a way to maintain compliance after deployment. USDM brings the regulatory depth, technology expertise, and digital quality approach needed to support continuous verification, strengthen AI oversight, and keep regulated organizations inspection ready as AI scales.

Learn More Read the Case Study

Meet the agent layer

AI deployment gets real when an agent has a job.

USDM designs agents around bounded domain work: what the agent can draft, retrieve, summarize, route, or flag — and where a qualified human stays accountable. That is how AI becomes workflow, not theater with a login screen.

Quality Agent

What it helps with

Deviation intake, CAPA starters, complaint triage, and evidence assembly.

Business outcome

Shorter quality queues with reviewable source context for the quality owner.

Meet the agent

Regulatory Agent

What it helps with

Change-impact packs, submission source gathering, commitment tracking, and Q&A prep.

Business outcome

Less document chasing and faster regulatory review without losing filing control.

Meet the agent

Clinical Agent

What it helps with

Protocol support, site-startup follow-up, study trackers, and meeting actions.

Business outcome

Cleaner clinical coordination while sponsor and medical judgment stay human-owned.

Meet the agent

Manufacturing Agent

What it helps with

Batch-record support, shift handoffs, exception triage, and production summaries.

Business outcome

Faster operational handoffs with release and disposition decisions still protected.

Meet the agent

The pattern: start with a workflow, assign the agent a bounded role, keep the human decision point explicit, and capture enough context that the work can be reviewed, improved, and trusted.

Recent AI resources

Fresh thinking for governed AI deployment.

The newest USDM resources from the last 45 days covering AI readiness, agentic workflows, Claude governance, enterprise knowledge, and the controls needed to deploy AI in regulated life sciences work.

BlogMay 28, 2026

Where Glean Fits in the Enterprise AI Stack

A practical look at how Glean fits into the enterprise AI ecosystem as a governed work AI layer across knowledge, permissions, assistants, agents, and workflows.

Read resource

BlogMay 27, 2026

AI Governance Is No Longer Just a Technology Problem

AI is becoming an operational dependency for life sciences organizations. Brian Rankin explains why governance maturity, concentration-risk oversight, and executive accountability need to evolve with adoption.

Read resource

BlogMay 27, 2026

Trusted to Do Their Part: The Future of USDM Cloud Assurance

The USDM Cloud Assurance team explains how continuous evidence, attestable reasoning, calibrated autonomy, and human attestation shape trust for AI-bearing regulated software.

Read resource

Deep dives

Go deeper on the topics that matter most.

Explore detailed briefs on high-priority regulatory, compliance, and AI topics — each connecting USDM expertise to the specific challenges your organization faces.

AI readiness assessment

AI Readiness Assessment for Life Sciences

USDM's AI Readiness Assessment helps life sciences teams evaluate AI maturity, data readiness, governance, validation risk, and use-case priority.

Read now

AI Governance + Compliance

AI Governance + Compliance in Life Sciences: Building Workflows You Can Defend

AI Governance + Compliance helps life sciences teams deploy AI through controlled workflows, validation discipline, and defensible oversight in regulated environments.

Read now

AI Strategy + Consulting

AI Strategy + Consulting in Life Sciences: Turning Vision into Deployed Workflows

AI Strategy + Consulting helps life sciences organizations move from AI ambition to governed deployment, scalable workflows, and measurable operational value.

Read now

AI Trust, Risk, and Oversight

AI Trust, Risk, and Oversight in Life Sciences: Designing Deployment for Accountability

AI Trust, Risk, and Oversight gives life sciences organizations a practical way to deploy AI with accountability, explainability, and defensible controls.

Read now

Applied AI Use Cases

Applied AI Use Cases in Life Sciences: Where Workflow Value Becomes Real

Applied AI Use Cases show how life sciences teams can deploy AI into quality, regulatory, clinical, and validation workflows without losing control or oversight.

Read now

Explore

Proof and guidance across this practice area

Case studies, blogs, webinars, and guides connected to this capability.

Blog

Evaluating Google Agentspace for Life Sciences

A practical 10-factor framework for life sciences teams evaluating Google Agentspace—covering GxP compliance, data security, auditability, multi-agent governance, and ROI for confident, validated AI adoption.

Read

White Paper

2023 Technology Trends in Life Sciences

Explore five technology trends—automation, data collaboration platforms, cloud landing zones, AR/VR, and IoT—that help pharma, biotech, and medical device companies modernize while staying compliant. Download the white paper.

Read

AI deploymentGovernance

Daily Monitoring Enables Immediate Action for Security Issues and Continuous Compliance

Clinical-stage pharmaceutical company running clinical trials under global regulatory oversight, using a Clinical Data Management System (CDMS) with admin-level / Vault Owner access controls.

Learn how using a CDMS audit trail supported daily security monitoring, helped detect critical issues, and enabled swift resolutions.

Detection-to-Action Window

Within 24 hours

See proof

Blog

Beyond Automation: Orchestrating the Future of Validation with GenAI and ProcessX

How ProcessX helps life sciences teams govern GenAI-enabled validation workflows, agentic actions, Veeva integration, human review, and audit-ready evidence.

Read

AI deploymentGovernance

From Legacy Systems to Intelligent Content Planning

A clinical-stage biopharmaceutical company with a growing clinical pipeline, modernizing fragmented legacy regulatory information management (RIM) systems across its regulatory, clinical, and quality functions.

A biopharma’s journey from legacy RIM systems to intelligent content planning—powered by USDM’s strategic, AI-ready approach.

Annual Savings

$61K+

See proof

Blog

90-Day AI Readiness for Life Sciences

A 90-day AI readiness assessment for life sciences: inventory use cases, classify risk, map data and platform controls, select pilots, and build a governed adoption roadmap.

Read

Frequently Asked Questions

Questions leaders ask before they move.

What is AI strategy in life sciences, and why does it matter now?

AI strategy is the structured plan for identifying, governing, implementing, and scaling AI in regulated environments. It matters because AI is already embedded in platforms and workflows, and unmanaged adoption is harder to govern or defend.

Why do pharma and biotech companies need specialized AI consulting?

Regulated AI initiatives must align with GxP expectations, validation requirements, data governance standards, and evolving global regulations. Specialized consulting combines technical deployment with life sciences compliance and operational reality.

What should executives look for in a life sciences AI consulting partner?

Executives should look for AI expertise plus deep life sciences domain knowledge, including regulated systems, data integrity, quality operations, validation, enterprise change management, readiness assessment, governance, and implementation support.

How do life sciences organizations move from AI strategy to AI implementation?

They prioritize use cases by value, system readiness, data readiness, and governance requirements, then move through readiness assessment, governance definition, focused pilots, validation of results, and scaled workflow deployment.

What are the biggest risks of AI implementation in regulated life sciences environments?

Major risks include poor governance, unclear intended use, weak data controls, lack of validation planning, vendor overreliance, model drift, explainability gaps, auditability gaps, and unclear accountability.

How can executives measure success from life sciences AI consulting and implementation?

Success should be measured through business and compliance outcomes: reduced cycle times, lower compliance costs, faster decisions, stronger inspection readiness, clearer AI ownership, better governance maturity, and scalable operations.

Why does AI strategy need to end in workflow design?

AI strategy only creates value when it turns into controlled workflows teams can actually use. The work has to connect business priorities, process design, change management, data readiness, and deployment planning.

What good AI consulting looks like in pharma and biotech?

Good consulting combines domain knowledge, regulatory awareness, workflow redesign, and validated systems so AI deployment improves execution without breaking compliance.

What does regulated AI require?

When AI influences quality, regulatory, clinical, or manufacturing work, organizations need controls around inputs, outputs, review, traceability, and change so the workflow remains governed and defensible.

How do you keep AI trustworthy after deployment?

Trust comes from visibility, review discipline, and continuous oversight. Teams need clear intervention points, documented exception handling, and monitoring that shows the workflow still behaves as intended over time.